KK
STOK icon

KLP Kapitalforvaltning’s Stoke Therapeutics STOK Stock Holding History

KLP Kapitalforvaltning’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
8,800
+600
+7% +$19.7K ﹤0.01% 1681
2025
Q4 		$260K Sell
8,200
-1,400
-15% -$42.1K ﹤0.01% 1741
2025
Q3 		$226K Sell
9,600
-3,600
-27% -$61.7K ﹤0.01% 1781
2025
Q2 		$150K Buy
13,200
+7,500
+132% +$71.2K ﹤0.01% 1890
2025
Q1 		$37.9K Hold
5,700
– – ﹤0.01% 2219
2024
Q4 		$62.9K Buy
+5,700
New +$70K ﹤0.01% 2211

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

KLP Kapitalforvaltning's STOK Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Stoke Therapeutics (STOK) stake by 7.3% in Q1 2026, buying an estimated $19.7K and bringing the position to 8,800 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

KLP Kapitalforvaltning first reported a position in STOK in Q4 2024 and has held it in 6 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • KLP Kapitalforvaltning held 8,800 shares of Stoke Therapeutics worth $287K as of Q1 2026.
  • KLP Kapitalforvaltning bought 600 Stoke Therapeutics shares in Q1 2026, an estimated $19.7K.
  • Stoke Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1681 holding.
  • KLP Kapitalforvaltning first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.